Current and potential methods for second trimester abortion.

[1]  C. Goldfarb,et al.  Intrafetal Injection of Lidocaine to Induce Fetal Demise , 2019, Contraception.

[2]  T. Shochet,et al.  Could second-trimester medical abortion be offered as a day service? Assessing the feasibility of a 1-day outpatient procedure using pooled data from six clinical studies. , 2019, Contraception.

[3]  P. Blumenthal,et al.  Self-administered lidocaine gel for local anesthesia prior to osmotic dilator placement: a randomized trial. , 2019, Contraception.

[4]  D. Jamieson,et al.  Abortion Surveillance — United States, 2014 , 2018, Morbidity and mortality weekly report. Surveillance summaries.

[5]  C. Gerdts,et al.  Second-trimester medication abortion outside the clinic setting: an analysis of electronic client records from a safe abortion hotline in Indonesia , 2018, BMJ Sexual & Reproductive Health.

[6]  D. Costescu,et al.  No. 360-Induced Abortion: Surgical Abortion and Second Trimester Medical Methods. , 2018, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[7]  P. Blumenthal,et al.  Investigation of a variable mifepristone to misoprostol interval for second trimester medical abortion , 2018 .

[8]  P. Blumenthal,et al.  Preoperative effects of mifepristone for dilation and evacuation after 19 weeks of gestation: a randomised controlled trial , 2017, BJOG : an international journal of obstetrics and gynaecology.

[9]  Angela Y. Chen,et al.  Comparison of complications associated with induction by misoprostol versus dilation and evacuation for second‐trimester abortion , 2017, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[10]  B. Kaneshiro,et al.  Paracervical Block for Laminaria Insertion Before Second-Trimester Abortion: A Randomized Controlled Trial. , 2017, Obstetrics and gynecology.

[11]  J. Trussell,et al.  Self reported outcomes and adverse events after medical abortion through online telemedicine: population based study in the Republic of Ireland and Northern Ireland , 2017, British Medical Journal.

[12]  B. Winikoff,et al.  Second trimester medical abortion with mifepristone followed by unlimited dosing of buccal misoprostol in Armenia , 2017, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[13]  D. Grossman,et al.  Sixteen Years of Overregulation: Time to Unburden Mifeprex. , 2017, The New England journal of medicine.

[14]  N. Ngoc,et al.  Simultaneous Administration Compared With a 24-Hour Mifepristone–Misoprostol Interval in Second-Trimester Abortion: A Randomized Controlled Trial , 2016, Obstetrics and gynecology.

[15]  C. Westhoff,et al.  Intra-fetal Compared With Intra-amniotic Digoxin Before Dilation and Evacuation: A Randomized Controlled Trial , 2016, Obstetrics and gynecology.

[16]  S. Achilles,et al.  Synthetic osmotic dilators with adjunctive misoprostol for same-day dilation and evacuation: a randomized controlled trial. , 2016, Contraception.

[17]  L. Myer,et al.  Clinical Outcomes and Women’s Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa , 2016, PloS one.

[18]  M. Reeves,et al.  A randomized controlled trial evaluating same-day mifepristone and misoprostol compared to misoprostol alone for cervical preparation prior to second-trimester surgical abortion. , 2016, Contraception.

[19]  B. R. Johnson,et al.  Abortion incidence between 1990 and 2014: global, regional, and subregional levels and trends , 2016, The Lancet.

[20]  Ashlesha Patel,et al.  Misoprostol 1 to 3 h preprocedure vs. overnight osmotic dilators prior to early second-trimester surgical abortion. , 2015, Contraception.

[21]  R. A. Al,et al.  Vaginal Misoprostol Compared With Buccal Misoprostol for Termination of Second-Trimester Pregnancy: A Randomized Controlled Trial , 2015, Obstetrics and gynecology.

[22]  G. Fitzmaurice,et al.  Cervical Preparation Before Dilation and Evacuation Using Adjunctive Misoprostol or Mifepristone Compared With Overnight Osmotic Dilators Alone: A Randomized Controlled Trial , 2015, Obstetrics and gynecology.

[23]  T. Shochet,et al.  A double‐blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14–21 weeks of pregnancy , 2015, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[24]  P. Blumenthal,et al.  Adjunct mifepristone for cervical preparation prior to dilation and evacuation: a randomized trial. , 2015, Contraception.

[25]  D. Grossman,et al.  Incidence of emergency department visits and complications after abortion. , 2015, Obstetrics and gynecology.

[26]  R. Mercier,et al.  Intrauterine lidocaine for pain control during laminaria insertion: a randomized controlled trial. , 2014, Contraception.

[27]  D. Constant,et al.  A randomized trial of misoprostol versus laminaria before dilation and evacuation in South Africa. , 2014, Contraception.

[28]  D. Doherty,et al.  Mifepristone and Oral, Vaginal, or Sublingual Misoprostol for Second-Trimester Abortion: A Randomized Controlled Trial , 2014, Obstetrics and gynecology.

[29]  O. Vragovic,et al.  Mifepristone and Misoprostol Compared With Osmotic Dilator Insertion Before Surgical Abortion at 15–18 Weeks , 2014 .

[30]  J. Steinauer,et al.  Buccal misoprostol plus laminaria for cervical preparation before dilation and evacuation at 21-23 weeks of gestation: a randomized controlled trial. , 2014, Contraception.

[31]  C. Krajewski,et al.  Cervical preparation for second-trimester surgical abortion prior to 20 weeks' gestation: SFP Guideline #2013-4. , 2014, Contraception.

[32]  M. Gissler,et al.  Medical termination of pregnancy during the second versus the first trimester and its effects on subsequent pregnancy. , 2014, Contraception.

[33]  J. Steinauer,et al.  Same-Day Synthetic Osmotic Dilators Compared With Overnight Laminaria Before Abortion at 14–18 Weeks of Gestation: A Randomized Controlled Trial , 2014, Obstetrics and gynecology.

[34]  T. Tongsong,et al.  Randomized controlled trial comparing efficacy between a vaginal misoprostol loading and non‐loading dose regimen for second‐trimester pregnancy termination , 2014, The journal of obstetrics and gynaecology research.

[35]  N. Rojansky,et al.  Mifepristone Followed by Misoprostol or Oxytocin for Second-Trimester Abortion: A Randomized Controlled Trial , 2013, Obstetrics and gynecology.

[36]  R. Maurer,et al.  Buccal Misoprostol Compared With Synthetic Osmotic Cervical Dilator Before Surgical Abortion: A Randomized Controlled Trial , 2013, Obstetrics and gynecology.

[37]  P. Blumenthal,et al.  Mifepristone–Misoprostol Dosing Interval and Effect on Induction Abortion Times: A Systematic Review , 2013, Obstetrics and gynecology.

[38]  Practice Bulletin No. 135: Second-Trimester Abortion , 2013, Obstetrics and gynecology.

[39]  D. Turok,et al.  Same-day cervical preparation with misoprostol prior to second trimester D&E: a case series. , 2011, Contraception.

[40]  M. Y. Hou,et al.  Mifepristone vs. osmotic dilator insertion for cervical preparation prior to surgical abortion at 14-16 weeks: a randomized trial. , 2011, Contraception.

[41]  M. Ghajarzadeh,et al.  Sublingual versus vaginal misoprostol for second trimester termination: a randomized clinical trial , 2012, Archives of Gynecology and Obstetrics.

[42]  A. Faúndes.  The combination of mifepristone and misoprostol for the termination of pregnancy , 2011, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[43]  N. Ngoc,et al.  Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-Trimester Abortion: A Randomized Controlled Trial , 2011, Obstetrics and gynecology.

[44]  N. Kapp,et al.  Clinical guidelines. Labor induction abortion in the second trimester. , 2011, Contraception.

[45]  Cochrane Abstract.  Medical Methods for Mid-Trimester Termination of Pregnancy , 2011, Obstetrics and gynecology.

[46]  E. Drey,et al.  Induction of fetal demise before abortion. , 2010, Contraception.

[47]  S. Newmann,et al.  Clinical guidelines. Cervical preparation for surgical abortion from 20 to 24 weeks' gestation. , 2008, Contraception.

[48]  P. Lohr,et al.  Surgical versus medical methods for second trimester induced abortion. , 2008, The Cochrane database of systematic reviews.

[49]  S. Lalitkumar,et al.  Second Trimester Medical Abortion with Mifepristone–Misoprostol and Misoprostol Alone: A Review of Methods and Management , 2008, Reproductive health matters.

[50]  P. Stubblefield,et al.  Mifepristone in Second-Trimester Medical Abortion: A Randomized Controlled Trial , 2007, Obstetrics and gynecology.

[51]  P. Ho,et al.  Misoprostol: Pharmacokinetic profiles, effects on the uterus and side‐effects , 2007, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[52]  S. Lalitkumar,et al.  Mid-trimester induced abortion: a review. , 2007, Human reproduction update.

[53]  M. Fox,et al.  Cervical preparation for second-trimester surgical abortion prior to 20 weeks of gestation. , 2007, Contraception.

[54]  S. Bertisch,et al.  Misoprostol Administered by Epithelial Routes: Drug Absorption and Uterine Response , 2006, Obstetrics and gynecology.

[55]  Ashlesha Patel,et al.  Adequacy and safety of buccal misoprostol for cervical preparation prior to termination of second-trimester pregnancy. , 2006, Contraception.

[56]  M. Goetsch,et al.  Cervical preparation using laminaria with adjunctive buccal misoprostol before second-trimester dilation and evacuation procedures: a randomized clinical trial. , 2006, American journal of obstetrics and gynecology.

[57]  A. Whitaker,et al.  Misoprostol Compared With Laminaria Before Early Second-Trimester Surgical Abortion: A Randomized Trial , 2005, Obstetrics and gynecology.

[58]  P. Stubblefield,et al.  Methods for induced abortion. , 2004, Obstetrics and gynecology.

[59]  D. Grimes,et al.  Mifepristone and misoprostol versus dilation and evacuation for midtrimester abortion: a pilot randomised controlled trial , 2004, BJOG : an international journal of obstetrics and gynaecology.

[60]  S. Suhonen,et al.  One- and 2-day mifepristone-misoprostol intervals are both effective in medical termination of second-trimester pregnancy. , 2004, Reproductive biomedicine online.

[61]  R. Kirby,et al.  A comparison of medical induction and dilation and evacuation for second-trimester abortion. , 2002, American journal of obstetrics and gynecology.

[62]  P. Ho,et al.  Pharmacokinetics of different routes of administration of misoprostol. , 2002, Human reproduction.

[63]  N. Benowitz,et al.  Absorption Kinetics of Misoprostol With Oral or Vaginal Administration , 1997, Obstetrics and gynecology.

[64]  A. Templeton,et al.  Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens. , 1995, Human reproduction.

[65]  Berry Fn,et al.  Second-trimester abortion by dilatation and evacuation: an analysis of 11,747 cases. , 1983 .

[66]  M. Grace,et al.  Second-Trimester Abortion by Dilatation and Evacuation: An Analysis of 11,747 Cases , 1983, Obstetrics and gynecology.